Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
The National Cancer Institute (NCI) is offering a funding opportunity to support the validation of biomarkers and assays used in cancer detection and treatment. The focus is on accelerating the adoption of these tools for various purposes, such as predicting treatment responses and monitoring cancer progression. Applicants must have analytically validated assays suitable for clinical use. The …
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to accelerate the adoption and validation of molecular/cellular/imaging markers (referred to as "markers" or "biomarkers") and assays for cancer detection, diagnosis, prognosis, monitoring, and predict…
Funding Source
Awards & funding
Dates
Documents
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers